The estimated Net Worth of Marschall S Runge is at least $14.5 Million dollars as of 1 March 2022. Marschall Runge owns over 202 units of Lilly(Eli) & Co stock worth over $14,214,858 and over the last 11 years he sold LLY stock worth over $0. In addition, he makes $294,000 as Independent Director at Lilly(Eli) & Co.
Marschall has made over 1 trades of the Lilly(Eli) & Co stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 202 units of LLY stock worth $49,850 on 1 March 2022.
The largest trade he's ever made was buying 202 units of Lilly(Eli) & Co stock on 1 March 2022 worth over $49,850. On average, Marschall trades about 17 units every 0 days since 2013. As of 1 March 2022 he still owns at least 15,436 units of Lilly(Eli) & Co stock.
You can see the complete history of Marschall Runge stock trades at the bottom of the page.
Dr. Marschall S. Runge M.D. Ph.D. serves as Independent Director of the Company. Dr. Runge brings the unique perspective of a practicing physician who has a broad background in health care and academia. He has extensive experience as a practicing cardiologist, a strong understanding of health care facility systems, and deep expertise in biomedical research and clinical trial design.
As the Independent Director of Lilly(Eli) & Co, the total compensation of Marschall Runge at Lilly(Eli) & Co is $294,000. There are 15 executives at Lilly(Eli) & Co getting paid more, with David Ricks having the highest compensation of $21,283,200.
Marschall Runge is 65, he's been the Independent Director of Lilly(Eli) & Co since 2013. There are 3 older and 28 younger executives at Lilly(Eli) & Co. The oldest executive at Lilly(Eli) & Co is Kathi Seifert, 71, who is the Independent Director.
Marschall's mailing address filed with the SEC is Eli Lilly and Company Corporate Center, Indianapolis, Marion County, Indiana, United States.
Over the last 20 years, insiders at Lilly(Eli) & Co have traded over $29,994,829,903 worth of Lilly(Eli) & Co stock and bought 73,808 units worth $5,778,435 . The most active insiders traders include Endowment Inc Lilly, R David Hoover, and Lorenzo Tallarigo. On average, Lilly(Eli) & Co executives and independent directors trade stock every 7 days with the average trade being worth of $55,447,708. The most recent stock trade was executed by Endowment Inc Lilly on 3 September 2024, trading 24,084 units of LLY stock currently worth $23,281,762.
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.
Lilly(Eli) & Co executives and other stock owners filed with the SEC include: